We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Prognosis of Atypical Pituitary Adenomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00473369
Recruitment Status : Unknown
Verified May 2007 by Tohoku University.
Recruitment status was:  Active, not recruiting
First Posted : May 15, 2007
Last Update Posted : May 15, 2007
Sponsor:
Information provided by:

Study Description
Brief Summary:

Context: Pituitary adenoma is generally indolent, but an aggressive subtype called atypical adenoma has uncertain prognosis, and an unclear relationship between prognosis and morphology.

Objective: This study investigated the prognostic factors of this tumor. Design: Retrospective analysis. Setting: University and associated hospitals.


Condition or disease
Pituitary Diseases

Study Design

Study Type : Observational
Observational Model: Case Control
Observational Model: Natural History
Time Perspective: Cross-Sectional
Time Perspective: Retrospective
Study Start Date : January 2001
Estimated Study Completion Date : May 2007

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years to 74 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • pituitary adenomas of more than 3 % of Ki67 labeling index surgically treated at Tohoku university and associated hospital

Exclusion Criteria:

  • pituitary adenomas of less than 3 % of Ki-67 labeling index surgically treated at Tohoku university and associated hospital
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00473369


Sponsors and Collaborators
Tohoku University
Investigators
Principal Investigator: Yoshikazu Ogawa, M. D. Department of neurosurgery, Tohoku university
More Information

ClinicalTrials.gov Identifier: NCT00473369     History of Changes
Other Study ID Numbers: 1-2007.nsg.med.tohoku
First Posted: May 15, 2007    Key Record Dates
Last Update Posted: May 15, 2007
Last Verified: May 2007

Keywords provided by Tohoku University:
atypical adenoma
Ki-67
p53
pituitary
prognosis

Additional relevant MeSH terms:
Pituitary Diseases
Hypothalamic Diseases
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Endocrine System Diseases